Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002101269 | SCV002394355 | likely benign | Hereditary pheochromocytoma-paraganglioma | 2023-05-13 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258380 | SCV002535915 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-21 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002258380 | SCV002632141 | likely benign | Hereditary cancer-predisposing syndrome | 2019-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV005242171 | SCV005893868 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | MAX: BP4, BP7 |